What a Pharma CRM Actually Costs — and Why Nobody Will Tell You
24 Aug 2026 · 7 min read
If you run the commercial side of a distributor with ten reps, you have probably done this: opened the website of a pharma CRM, looked for the pricing page, and found a button that says Contact Sales.
That is not an oversight. It is the model.
The prices are not hidden by accident
Go to Veeva's Commercial Cloud page today and you will find a product list — Vault CRM Suite, PromoMats, Medical, Crossix, Data Cloud, an Agentic Call Report — and a telephone number. No price. The Vault CRM page is the same. There is no pricing page to miss.
This is normal at the enterprise end of the market, and there is a rational reason for it: when a deal ranges from a mid-sized affiliate to a global top-20 rollout, one published number would be wrong for almost everyone. Quote-only pricing lets the vendor size the deal to the buyer.
The consequence for you is less comfortable. Price discovery costs you time before it costs you money. You cannot compare three options in an afternoon. You enter a sales process to learn a number, and the sales process is designed around a buyer much larger than you.
What is actually in the quote
When the number finally arrives, it is rarely one number. In enterprise CRM the total tends to break into five lines, and only the first is the one people quote in the corridor.
- The licence. Priced per user, per month, billed annually. This is the figure that gets repeated internally and it is usually the smallest part of year one.
- The minimum. Many enterprise contracts carry a floor — a minimum seat count or a minimum annual commitment. If the floor is above your headcount, you pay for reps you do not have. This is the single most common reason a small distributor's quote comes back at a number that seems disconnected from team size.
- Implementation. Configuration, data migration, integration with whatever holds your product and customer master. Often a separate statement of work, often delivered by a partner rather than the vendor, and frequently comparable to the first year of licences.
- The admin you did not budget for. Enterprise CRM assumes someone owns it. In a large affiliate that person exists. In a ten-rep distributor it becomes a slice of your week, permanently, or a retained consultant.
- The term. Multi-year commitments with annual uplift are standard. The number you agree in year one is not the number in year three.
None of that is dishonest. It is simply what a platform built for a global commercial organisation costs to run. The mismatch is not the price — it is the shape.
The question that actually settles it
Before comparing quotes, answer one question honestly: what are you buying it for?
A large pharma organisation buys CRM to satisfy several things at once — closed-loop marketing, sample accountability, e-detailing, MLR-approved content, regulatory reporting across markets. The platform is expensive because it carries all of that.
A distributor with ten reps usually wants something much narrower. In practice it is almost always these four:
- Who was actually visited last week
- What was objected to, and whether the same objection keeps coming back
- What was committed, and by when
- Which accounts have gone quiet past our cadence
If that is the list, you are not shopping for a commercial platform. You are shopping for a reliable record of field activity — and paying platform prices for it is how small distributors end up with an expensive system that three reps quietly stop updating.
Per-seat pricing does something you should look at closely
Most CRM is priced per user per month. That feels fair, and for a large organisation it is.
For a small team it has a specific effect worth naming: it puts a price on growing the field force. Add two reps for a new region and your software cost rises the same month, before those reps have produced anything. It also creates a quiet incentive to under-license — to leave the part-time rep, the medical advisor, or the manager who wants read-only visibility off the system. Every person left off is a hole in exactly the record you bought the system to get.
Flat pricing banded by team size does not do this. You pay one figure for a band, and adding a rep inside the band costs nothing. Whether that matters depends entirely on whether you expect the team to change size.
What to ask for, so the comparison is real
If you are going into a quote process, ask for these in writing. All five are reasonable, and a vendor who will not answer them in writing is telling you something.
- The all-in year-one figure — licences, implementation, migration, training, everything.
- The year-three figure, with the uplift mechanism stated.
- The minimum commitment — seats and value, and what happens if headcount falls.
- What happens to your data if you leave — export format, who owns it, what it costs.
- Who administers it, and how many hours a month that realistically takes.
Then divide the all-in year-one figure by your actual rep count. That per-rep-per-year number is the only one that compares cleanly across vendors, and it is usually a long way from the per-user-per-month figure in the brochure.
Where RepMind sits, plainly
We publish our prices, so you can do the arithmetic above without talking to anyone.
| Plan | Team | Price |
|---|---|---|
| Solo | 1 rep, 15 visits/month | Free, no card |
| Starter | up to 5 reps | €1,990/year |
| Growth | up to 12 reps | €3,990/year |
| Country | up to 25 reps | €6,990/year |
Flat per company, not per seat. Adding a rep inside a band costs nothing. Prices exclude VAT — a VAT-registered EU business that supplies a valid VAT number is reverse-charged and pays the listed figure exactly.
We should be equally plain about what that money does not buy. RepMind is not a commercial platform. There is no closed-loop marketing, no MLR content approval, no sample accountability, no e-detailing. If your business needs those, you need one of the platforms, and the quote process is unavoidable.
What it does is the narrow list above: reps speak one sentence after each visit, in their own language, and it becomes a structured record — doctor, clinic, product, objection, commitment, next step — that a manager can read on Monday morning without asking anyone for an update.
The honest summary
Enterprise pharma CRM is not overpriced. It is priced for a different customer than a ten-rep distributor, and the quote process exists because that customer varies enormously.
If you are that customer, run the five questions above and get real comparable numbers.
If you are not — if what you actually need is a trustworthy record of what happened in the field — then the useful test is much simpler than a procurement exercise. Take the number, divide it by your reps, and ask whether the four things on your list are worth that per rep per year.
You can work that out for RepMind in about ten seconds, which is rather the point of publishing it.
Read next
How to Automate Your Pharma Call Reports (and Stop Losing Evenings to Admin)
Reps lose hours a week to call reports. Here's how AI visit-capture automates them — talk for 30 seconds, get a clean CRM entry. Practical guide + tools.
6 min read
The Best Veeva Alternatives for Reps Who Hate Data Entry (2026)
Looking for a Veeva alternative? Here's how to think about it in 2026 — full-suite CRMs vs. AI capture layers that just make reps' admin disappear.
5 min read
AI for Medical Reps: What Actually Works in the Field (2026)
Cut through the hype. Here are the AI use-cases that genuinely help medical reps — voice visit-capture, next-best-action, and multi-language reporting.
5 min read
Daily Call Report (DCR) Format for Medical Reps: What Actually Belongs In It
What actually belongs in a medical rep's daily call report, with a copy-paste template, real filled examples, and how to cut the time it takes to under five minutes.
6 min read
Tour Plan Format for Medical Reps: Two Filled Examples and Why Plans Get Rejected
The monthly tour plan format medical representatives actually use, two filled examples, the five reasons a TP gets rejected, and a copy-paste template you can use today.
7 min read
12 Doctor Objections and Exactly What to Say Back
The twelve objections medical reps hear most, from "I am busy" to "your price is high", with word-for-word responses that came from real field calls, not a script deck.
8 min read
Joint Field Work Report Format: The Form, and How to Use It Without Killing Trust
A joint field work report format that coaches instead of inspects, with a scored observation form, behavioural anchors, a filled example, and how many JFW days per rep actually work.
7 min read
RCPA in Pharma: How to Actually Do It, and What the Numbers Mean
What RCPA means, what you are really measuring, the three questions that work on a chemist, the sheet field by field with a filled example, and how fake RCPA gets caught.
7 min read
MR Reporting in Excel vs Software: An Honest Comparison
An honest comparison from someone who sells the software. What a spreadsheet genuinely does well, the four things that break it, and the exact team size where it stops working.
7 min read
POB in Pharma: What It Means and How to Increase It
POB in pharma explained by field people: what the full form actually is, how an order is raised, why POB never matches secondary sales, and seven honest ways to raise it.
7 min read
Your Field Reports Are Written From Memory — and Everyone Knows It
Why Friday-afternoon call reports stop being useful, what a manager actually loses when the record is reconstructed, and what a trustworthy field record requires.
7 min read
GDPR and Pharma Call Reporting: What a Small Distributor Actually Has to Think About
Field reps record notes about named doctors. That is personal data. A practical walk through where the questions sit for a small pharma or medtech distributor.
8 min read